Annual Cash & Cash Equivalents:
$1.70B+$489.50M(+40.53%)Summary
- As of today, UTHR annual cash & cash equivalents is $1.70 billion, with the most recent change of +$489.50 million (+40.53%) on December 31, 2024.
- During the last 3 years, UTHR annual cash & cash equivalents has risen by +$802.40 million (+89.67%).
- UTHR annual cash & cash equivalents is now at all-time high.
Performance
UTHR Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$2.77B-$281.10M(-9.22%)Summary
- As of today, UTHR quarterly cash & cash equivalents is $2.77 billion, with the most recent change of -$281.10 million (-9.22%) on September 30, 2025.
- Over the past year, UTHR quarterly cash & cash equivalents has dropped by -$558.90 million (-16.80%).
- UTHR quarterly cash & cash equivalents is now -16.80% below its all-time high of $3.33 billion, reached on September 30, 2024.
Performance
UTHR Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
UTHR Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +40.5% | -16.8% |
| 3Y3 Years | +89.7% | +5.8% |
| 5Y5 Years | +129.8% | +75.1% |
UTHR Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +89.7% | -16.8% | +5.8% |
| 5Y | 5-Year | at high | +129.8% | -16.8% | +75.1% |
| All-Time | All-Time | at high | >+9999.0% | -16.8% | >+9999.0% |
UTHR Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $2.77B(-9.2%) |
| Jun 2025 | - | $3.05B(-8.2%) |
| Mar 2025 | - | $3.32B(+1.7%) |
| Dec 2024 | $1.70B(+40.5%) | $3.27B(-1.8%) |
| Sep 2024 | - | $3.33B(+11.9%) |
| Jun 2024 | - | $2.97B(+9.7%) |
| Mar 2024 | - | $2.71B(-9.6%) |
| Dec 2023 | $1.21B(+25.6%) | $2.99B(+4.1%) |
| Sep 2023 | - | $2.88B(+7.3%) |
| Jun 2023 | - | $2.68B(-6.4%) |
| Mar 2023 | - | $2.86B(+0.9%) |
| Dec 2022 | $961.20M(+7.4%) | $2.84B(+8.5%) |
| Sep 2022 | - | $2.62B(+16.0%) |
| Jun 2022 | - | $2.26B(-0.6%) |
| Mar 2022 | - | $2.27B(+17.5%) |
| Dec 2021 | $894.80M(+21.1%) | $1.93B(-3.5%) |
| Sep 2021 | - | $2.00B(+1.7%) |
| Jun 2021 | - | $1.97B(+13.6%) |
| Mar 2021 | - | $1.73B(-5.7%) |
| Dec 2020 | $738.70M(+0.0%) | $1.83B(+16.1%) |
| Sep 2020 | - | $1.58B(+1.3%) |
| Jun 2020 | - | $1.56B(+1.0%) |
| Mar 2020 | - | $1.54B(+9.1%) |
| Dec 2019 | $738.40M(+10.3%) | - |
| Dec 2018 | $669.20M(-5.1%) | $1.42B(+52.7%) |
| Dec 2017 | $705.10M(-31.1%) | $927.40M(-4.9%) |
| Dec 2016 | $1.02B(+23.0%) | - |
| Mar 2016 | - | $975.10M(+121.5%) |
| Dec 2015 | $831.80M(+109.2%) | - |
| Jun 2015 | - | $440.13M(-42.1%) |
| Dec 2014 | $397.70M | - |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $760.49M(+283.4%) |
| Dec 2013 | $284.26M(+84.5%) | - |
| Dec 2012 | $154.03M(-5.3%) | - |
| Dec 2011 | $162.68M(-35.5%) | - |
| Dec 2010 | $252.16M(+151.3%) | - |
| Dec 2009 | $100.35M(-22.5%) | - |
| Dec 2008 | $129.45M(-7.1%) | - |
| Dec 2007 | $139.32M(+53.0%) | - |
| Jun 2007 | - | $198.37M(+139.6%) |
| Dec 2006 | $91.07M(+31.6%) | - |
| Dec 2005 | $69.18M(-16.2%) | - |
| Dec 2004 | $82.59M(+20.5%) | $82.79M(-4.2%) |
| Sep 2004 | - | $86.38M(+26.0%) |
| Dec 2003 | $68.56M(-44.1%) | $68.56M(-20.7%) |
| Sep 2003 | - | $86.44M(-5.1%) |
| Jun 2003 | - | $91.07M(-25.8%) |
| Dec 2002 | $122.66M(+403.2%) | $122.66M(-8.3%) |
| Sep 2002 | - | $133.81M(-9.5%) |
| Jun 2002 | - | $147.78M(+163.6%) |
| Dec 2001 | $24.37M(-87.9%) | $56.05M(-42.2%) |
| Sep 2001 | - | $96.98M(-40.6%) |
| Jun 2001 | - | $163.29M(-14.4%) |
| Mar 2001 | - | $190.72M(-5.1%) |
| Dec 2000 | $200.94M(+998.0%) | $200.94M(-10.4%) |
| Sep 2000 | - | $224.29M(+136.0%) |
| Jun 2000 | - | $95.04M(-7.5%) |
| Mar 2000 | - | $102.79M(+461.7%) |
| Dec 1999 | $18.30M(+169.1%) | $18.30M(+215.5%) |
| Sep 1999 | - | $5.80M(+28.9%) |
| Jun 1999 | - | $4.50M(-70.8%) |
| Mar 1999 | - | $15.40M |
| Dec 1998 | $6.80M | - |
FAQ
- What is United Therapeutics Corporation annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for United Therapeutics Corporation?
- What is United Therapeutics Corporation annual cash & cash equivalents year-on-year change?
- What is United Therapeutics Corporation quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for United Therapeutics Corporation?
- What is United Therapeutics Corporation quarterly cash & cash equivalents year-on-year change?
What is United Therapeutics Corporation annual cash & cash equivalents?
The current annual cash & cash equivalents of UTHR is $1.70B
What is the all-time high annual cash & cash equivalents for United Therapeutics Corporation?
United Therapeutics Corporation all-time high annual cash & cash equivalents is $1.70B
What is United Therapeutics Corporation annual cash & cash equivalents year-on-year change?
Over the past year, UTHR annual cash & cash equivalents has changed by +$489.50M (+40.53%)
What is United Therapeutics Corporation quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of UTHR is $2.77B
What is the all-time high quarterly cash & cash equivalents for United Therapeutics Corporation?
United Therapeutics Corporation all-time high quarterly cash & cash equivalents is $3.33B
What is United Therapeutics Corporation quarterly cash & cash equivalents year-on-year change?
Over the past year, UTHR quarterly cash & cash equivalents has changed by -$558.90M (-16.80%)